Pangea Biomed vs TrialJectory

Pangea Biomed vs TrialJectory, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Pangea Biomed is on 55/100 and TrialJectory on 58/100.

Pangea Biomed logo
Pangea BiomedBiotech company using AI and deep RNA analysis to predict cancer treatment response.
Try Pangea Biomed
TrialJectory logo
TrialJectoryAI-powered platform connecting cancer patients to advanced treatments and clinical trials.
Try TrialJectory

Where each one leads

Pangea Biomed

  • agent readiness: 39/100 against 32/100
  • headcount growth: +2.0% against -33.1%

TrialJectory

  • our overall score: 58/100 against 55/100
  • domain rating: 39/100 against 13/100
  • funding raised: $39.7M against $12.0M
  • LinkedIn following: 4,387 against 1,127

At a glance

MeasurePangea BiomedTrialJectory
What it isBiotech company using AI and deep RNA analysis to predict cancer treatment response.AI-powered platform connecting cancer patients to advanced treatments and clinical trials.
CategoryHealthcare, Oncology, Genomics, BiotechHealthcare, Clinical Trials, Cancer, HealthTech
Sells toBusiness modelB2B, B2CB2B
OfferingSoftwareSoftware
Founded20192017
HeadquartersTel Aviv, IsraelNew York, United States
StatusActiveActive

Size, funding and growth

MeasurePangea BiomedTrialJectory
Employees1617
Headcount growthLast 12 months+2.0%-33.1%
Total funding$12.0M$39.7M
Latest roundSeedSeries A
LinkedIn followers1,1274,387

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasurePangea BiomedTrialJectory
StartupHub scoreOur 0-100 rating55/10058/100
Traction48/10051/100
Team70/10070/100
Search visibility28/10036/100
Quality58/10062/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (32/100)
Domain ratingLink authority, 0-10013/10039/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasurePangea BiomedTrialJectory
HostingNot detectedAWS
CDNCloudflareCloudFront
CMSWordPressNot detected
FrameworksJquery, BootstrapNext.js

Pangea Biomed vs TrialJectory: common questions

Which is better, Pangea Biomed or TrialJectory?

On our 0-100 score TrialJectory rates higher (58/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do Pangea Biomed and TrialJectory compare on the numbers?

Pangea Biomed leads on agent readiness (39/100 against 32/100), headcount growth (+2.0% against -33.1%). TrialJectory leads on our overall score (58/100 against 55/100), domain rating (39/100 against 13/100), funding raised ($39.7M against $12.0M), LinkedIn following (4,387 against 1,127).

Read the full Pangea Biomed review and pricing or the TrialJectory review and pricing. You can also browse other Pangea Biomed alternatives we track.